{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:59:19Z","timestamp":1792648759394,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"am","delay-in-days":261,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL081785"],"award-info":[{"award-number":["HL081785"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL114611"],"award-info":[{"award-number":["R01 HL114611"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL62329"],"award-info":[{"award-number":["HL62329"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["OR120074"],"award-info":[{"award-number":["OR120074"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002727","name":"Ananda Mahidol Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002727","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bone.2021.116144","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T06:23:05Z","timestamp":1628403785000},"page":"116144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Engineered osteoclasts resorb necrotic alveolar bone in anti-RANKL antibody-treated mice"],"prefix":"10.1016","volume":"153","author":[{"given":"Worakanya","family":"Buranaphatthana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apichai","family":"Yavirach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Leaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Scatena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Y.","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia M.","family":"Giachelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2021.116144_bb0005","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons, American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2021.116144_bb0010","article-title":"Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015","author":"Khan","year":"2015","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116144_bb0015","doi-asserted-by":"crossref","unstructured":"M. R. Allen, S. L. Ruggiero, A review of pharmaceutical agents and oral bone health: how osteonecrosis of the jaw has affected the field., Int. J. Oral Maxillofac. Implants 29, e45\u201357.","DOI":"10.11607\/jomi.te41"},{"key":"10.1016\/j.bone.2021.116144_bb0020","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/j.ajpath.2014.07.010","article-title":"Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-\u03baB ligand antibody in mice","volume":"184","author":"Williams","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2021.116144_bb0025","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bone.2021.116144_bb0030","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2147\/BTT.S2082","article-title":"Denosumab: an investigational drug for the management of postmenopausal osteoporosis","volume":"2","author":"Lewiecki","year":"2008","journal-title":"Biol. Targets Ther."},{"key":"10.1016\/j.bone.2021.116144_bb0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11914-009-0004-5","article-title":"Denosumab: Anti-RANKL antibody","volume":"7","author":"Miller","year":"2009","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bone.2021.116144_bb0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1359\/jbmr.081112","article-title":"Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL","volume":"24","author":"Kostenuik","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116144_bb0045","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrd3244","article-title":"Denosumab","volume":"9","author":"Rizzoli","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"Suppl. 2","key":"10.1016\/j.bone.2021.116144_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jbmr.5650140212","article-title":"The pharmacology of bisphosphonates and new insights into their mechanisms of action","volume":"14","author":"Russell","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116144_bb0055","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002239900519","article-title":"Alendronate reduces adhesion of human osteoclast-like cells to bone and bone protein-coated surfaces","volume":"63","author":"Colucci","year":"1998","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2021.116144_bb0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.molmed.2004.05.007","article-title":"Bisphosphonates: new therapeutic agents for the treatment of bone tumors","volume":"10","author":"Heymann","year":"2004","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bone.2021.116144_bb0065","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","article-title":"Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo","volume":"10","author":"Hughes","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116144_bb0070","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00000421-200212001-00002","article-title":"Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis","volume":"25","author":"Green","year":"2002","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.bone.2021.116144_bb0075","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1006\/bbrc.2002.6510","article-title":"Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts","volume":"291","author":"Viereck","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2021.116144_bb0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1359\/jbmr.2004.19.1.147","article-title":"The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE)","volume":"19","author":"Pan","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116144_bb0085","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/0022034515572021","article-title":"Infection and medication-related osteonecrosis of the jaw","volume":"94","author":"Katsarelis","year":"2015","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2021.116144_bb0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.11005\/jbm.2015.22.4.151","article-title":"Medication related osteonecrosis of the jaw: 2015 position statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons","volume":"22","author":"Kim","year":"2015","journal-title":"J. Bone Metab."},{"key":"10.1016\/j.bone.2021.116144_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084465","article-title":"An inducible, ligand-independent receptor activator of NF-kB gene to control osteoclast differentiation from monocytic precursors","volume":"8","author":"Rementer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2021.116144_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13009","article-title":"Immunoglobulin G complexes without sialic acids enhance osteoclastogenesis but do not affect arthritis-mediated bone loss","volume":"93","author":"Sehic","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bone.2021.116144_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7651","article-title":"Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss","volume":"6","author":"Harre","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bone.2021.116144_bb0110","doi-asserted-by":"crossref","unstructured":"Y. Liu, Z. Li, M. Arioka, L. Wang, C. Bao, J. A. Helms, WNT3A accelerates delayed alveolar bone repair in ovariectomized mice. Osteoporos. Int. 30 (2019), doi:https:\/\/doi.org\/10.1007\/s00198-019-05071-x.","DOI":"10.1007\/s00198-019-05071-x"},{"key":"10.1016\/j.bone.2021.116144_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/0096-6347(47)90063-X","article-title":"The healing of extraction wounds in the presence of retained root remnants and bone fragments. An experimental study","volume":"33","author":"Glickman","year":"1947","journal-title":"Am. J. Orthod. Oral Surg."},{"key":"10.1016\/j.bone.2021.116144_bb0120","article-title":"Healing responses following transverse root fracture: a historical review and case reports showing healing with (a) calcified tissue and (b) dense fibrous connective tissue","volume":"29","author":"Ao","year":"2013","journal-title":"Dent. Traumatol."},{"key":"10.1016\/j.bone.2021.116144_bb0125","doi-asserted-by":"crossref","DOI":"10.1359\/jbmr.081210","article-title":"Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue","volume":"24","author":"Cardoso","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116144_bb0130","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-051X.2008.01246.x","article-title":"Modeling and remodeling of human extraction sockets","volume":"35","author":"Trombelli","year":"2008","journal-title":"J. Clin. Periodontol."},{"key":"10.1016\/j.bone.2021.116144_bb0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/10454411980090020401","article-title":"Is all bone the same? Distinctive distributions and properties of non-collagenous matrix proteins in lamellar vs. woven bone imply the existence of different underlying osteogenic mechanisms","volume":"9","author":"Gorski","year":"1998","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"10.1016\/j.bone.2021.116144_bb0140","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201801791RR","article-title":"Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw","volume":"33","author":"Zhu","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2021.116144_bb0145","article-title":"IL-17-mediated M1\/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws","volume":"19","author":"Shi","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2021.116144_bb0150","doi-asserted-by":"crossref","DOI":"10.1620\/tjem.248.27","article-title":"Antiresorptive agents and anti-angiogenesis drugs in the development of osteonecrosis of the jaw","volume":"248","author":"Allegra","year":"2019","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.bone.2021.116144_bb0155","doi-asserted-by":"crossref","DOI":"10.1007\/s00784-018-2385-2","article-title":"Bone mineralization and vascularization in bisphosphonate-related osteonecrosis of the jaw: an experimental study in the rat","volume":"22","author":"K\u00fcn-Darbois","year":"2018","journal-title":"Clin. Oral Investig."},{"key":"10.1016\/j.bone.2021.116144_bb0160","doi-asserted-by":"crossref","unstructured":"M. Q. S. Soares, J. Van Dessel, R. Jacobs, P. S. da Silva Santos, T. M. Cestari, G. P. Garlet, M. A. H. Duarte, T. S. N. Imada, I. Lambrichts, I. R. F. Rubira-Bullen, Zoledronic acid induces site-specific structural changes and decreases vascular area in the alveolar bone, J. Oral Maxillofac. Surg. 76 (2018), doi:https:\/\/doi.org\/10.1016\/j.joms.2018.03.007.","DOI":"10.1016\/j.joms.2018.03.007"},{"key":"10.1016\/j.bone.2021.116144_bb0165","doi-asserted-by":"crossref","DOI":"10.1177\/0022034517732770","article-title":"Zoledronate impairs socket healing after extraction of teeth with experimental periodontitis","volume":"97","author":"Soundia","year":"2018","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2021.116144_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115560","article-title":"Dynamic polarization shifting from M1 to M2 macrophages in reduced osteonecrosis of the jaw-like lesions by cessation of anti-RANKL antibody in mice","author":"Tamaki","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116144_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115308","article-title":"Distinct immunopathology in the early stages between different antiresorptives-related osteonecrosis of the jaw-like lesions in mice","volume":"135","author":"Hayano","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116144_bb0180","doi-asserted-by":"crossref","DOI":"10.1111\/j.1875-595X.2011.00004.x","article-title":"Reasons for extraction of permanent teeth in Greece: a five-year follow-up study","volume":"61","author":"Chrysanthakopoulos","year":"2011","journal-title":"Int. Dent. J."},{"key":"10.1016\/j.bone.2021.116144_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/odi.12632","article-title":"Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study","volume":"23","author":"Fung","year":"2017","journal-title":"Oral Dis."},{"key":"10.1016\/j.bone.2021.116144_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.37","article-title":"Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice","volume":"25","author":"Kikuiri","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116144_bb0195","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201901819RR","article-title":"Role of dendritic cell-mediated immune response in oral homeostasis: a new mechanism of osteonecrosis of the jaw","volume":"34","author":"Elsayed","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2021.116144_bb0200","article-title":"Athymic nude mice as an experimental model for cancer treatment","volume":"65","author":"Szadvari","year":"2016","journal-title":"Physiol. Res."},{"key":"10.1016\/j.bone.2021.116144_bb0205","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/467101","article-title":"From murine to human Nude\/SCID: the thymus, T-cell development and the missing link","volume":"2012","author":"Romano","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.bone.2021.116144_bb0210","article-title":"The nude mouse: a model of deficient T-cell function","volume":"7","author":"Pelleitier","year":"1975","journal-title":"Methods Achiev. Exp. Pathol."},{"key":"10.1016\/j.bone.2021.116144_bb0215","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M115.652305","article-title":"Osteonecrosis of the jaw developed in mice: disease variants regulated by \u03b3\u03b4 T cells in oral mucosal barrier immunity","volume":"290","author":"Park","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2021.116144_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2012.05.048","article-title":"Stem cell-delivery therapeutics for periodontal tissue regeneration","volume":"33","author":"Chen","year":"2012","journal-title":"Biomaterials"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221003100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221003100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:45:23Z","timestamp":1762659923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221003100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":44,"alternative-id":["S8756328221003100"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116144","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered osteoclasts resorb necrotic alveolar bone in anti-RANKL antibody-treated mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116144"}}